US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical Trials
Bharat Biotech Calls Out ‘Covishield vs Covaxin’ Comparative Study, Adds That Report Had Lot Of Flaws
Bharat Biotech’s Covaxin Shows 78 Percent Efficacy In Phase 3 Analysis
